Faster recovery after minimally invasive heart surgery
Treatments studied
Part of Heart & circulation, Pain clinical trials.
This study tests two ways to manage anesthesia during minimally invasive heart surgery: one uses a numbing injection near the spine plus a drug called dexmedetomidine, and the other uses traditional opioid painkillers. The goal is to see which approach helps you wake up faster and recover with fewer side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You are scheduled for minimally invasive heart surgery, such as mitral valve repair/replacement, aortic valve replacement, closure of a hole in the heart, or coronary bypass through small incisions.
- Your heart pumps well (ejection fraction of 45% or more) and you have a low surgical risk score.
- Your body mass index (BMI) is between 18 and 35.
- You do not have severe lung disease, sleep apnea, or require breathing support before surgery.
- You are not allergic to the study medications (dexmedetomidine, fentanyl, bupivacaine, propofol), and you are not on chronic opioids or have conditions that would prevent the numbing injection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests adding a medicine called dexmedetomidine to a standard pain-blocking injection (ropivacaine) used during heart surgery. The goal is to see if it reduces pain and speeds recovery better than the injection alone.
This trial tests whether adding a second medicine (dexmedetomidine) to the usual painkiller (bupivacaine) can improve pain relief after heart surgery. The medication is given as a nerve block before surgery to help you recover faster and with less pain.
This study is looking at a pain management approach that avoids using opioid painkillers during heart surgery in older adults. The goal is to see if this approach helps people recover faster after surgery with fewer side effects.
This trial tests whether adding a sedative medicine (dexmedetomidine) to a standard numbing medicine (ropivacaine) in a back nerve block gives better pain relief after heart bypass surgery. The goal is to reduce pain and improve recovery after your operation.
This study tests a faster-acting anesthesia method for minimally invasive heart valve surgery to help patients wake up sooner and recover more quickly. If you need heart valve surgery and are generally healthy enough, you may qualify to participate.
This study tests whether giving a medicine called dexmedetomidine before surgery can reduce pain during and after the operation. If it works, it might help people wake up feeling better and need less pain medicine.
Hear when a new Cardiac Disease Minimally Invasive Cardiac Surgery Postoperative Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.